Gus Alva, MD is medical director of ATP Clinical Research. He has served as a principal investigator for many years conducting investigation in a myriad of neuropsychiatric conditions: Alzheimer’s disease and other dementias, depression, anxiety disorders, bipolar disorder and psychotic conditions. As a clinician and investigator, Dr Alva’s focus is on the genetics, neuroimaging, and latest treatments available for all the afore mentioned conditions, as well as aspects of ethnicity and their correlation within clinical situations. He has published numerous articles, and presents at both national and international meetings and conferences. galva@theatpgroup.net

Bobby Shih is the director of Clinical Trials responsible for the conduction of the clinical research trials. While he performs many physical assessments, Bobby also performs cognitive assessments that assist in gauging the degree of impairment of our patients’ memory and executive functioning. He graduated from University of California, Irvine with a degree in Biological Sciences and Philosophy. bshih@theatpgroup.net

Marissa Rabe is a Clinical Research Coordinator and serves as the leading component in the implementation, execution and completion of ATP’s clinical research trials. Her previous experience in cardiovascular research has set the foundation for her understanding of the neuropsychiatric disorders that are examined at ATP. Marissa excels at both basic assessments, such as venipuncture and electrocardiograms, and cognitive examinations. Her strong rapport with patients has made trials with difficult and long procedures reasonable.. mrabe@theatpgroup.net

Mary Lykke, M.A., LMFT is a Research Recruiter in charge of gathering and educating potential research candidates. Mary is a Licensed Marriage Family Therapist with a Masters Degree in Clinical Psychology from Pepperdine University and a Bachelor’s of Arts in Psychology from University of California, Irvine. She has over 16 years of clinical experience & has been a research liaison since 1997. She has served as a sub-investigator on several Schizophrenia & Alzheimer’s clinical trials. Her strong relationship with community centers and key leaders in the community is paramount to ATP’s success in effectively meeting our recruitment outlines. Mary also conducts individual evaluation & educational meetings to enrich the community with knowledge regarding mental illness & clinical trials. mary@theatpgroup.net